Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126416742 | 12641674 | 2 | F | 20160901 | 20160810 | 20160915 | EXP | DE-PFIZER INC-2016380245 | PFIZER | ZSCHABITZ, S.. ACTIVITY OF IMMUNE CHECKPOINT INHIBITION IN PLATINUM REFRACTORY GERM-CELL TUMORS.. ANNALS OF ONCOLOGY. 2016;146:27(7):1356-1360 | 33.00 | YR | M | Y | 0.00000 | 20160915 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126416742 | 12641674 | 1 | PS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | UNK, CYCLIC (6 ? GOP, 4 ? GOP ) | 78339 | |||||||||||
| 126416742 | 12641674 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | UNK UNK, CYCLIC | 78813 | |||||||||||
| 126416742 | 12641674 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | UNK UNK, CYCLIC | 76131 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126416742 | 12641674 | 1 | Germ cell cancer |
| 126416742 | 12641674 | 2 | Germ cell cancer |
| 126416742 | 12641674 | 3 | Germ cell cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126416742 | 12641674 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126416742 | 12641674 | Pancytopenia | |
| 126416742 | 12641674 | Polyneuropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |